Unknown

Dataset Information

0

PDGFR? up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.


ABSTRACT: Control of BRAF(V600E) metastatic melanoma by BRAF inhibitor (BRAF-I) is limited by intrinsic and acquired resistance. Growth factor receptor up-regulation is among the mechanisms underlying BRAF-I resistance of melanoma cells. Here we demonstrate for the first time that PDGFR? up-regulation causes BRAF-I resistance. PDGFR? inhibition by PDGFR?-specific short hairpin (sh)RNA and by PDGFR? inhibitors restores and increases melanoma cells' sensitivity to BRAF-I in vitro and in vivo. This effect reflects the inhibition of ERK and AKT activation which is associated with BRAF-I resistance of melanoma cells. PDGFR? up-regulation is mediated by Sonic Hedgehog Homolog (Shh) pathway activation which is induced by BRAF-I treatment. Similarly to PDGFR? inhibition, Shh inhibition by LDE225 restores and increases melanoma cells' sensitivity to BRAF-I. These effects are mediated by PDGFR? down-regulation and by ERK and AKT inhibition. The clinical relevance of these data is indicated by the association of PDGFR? up-regulation in melanoma matched biopsies of BRAF-I +/- MEK inhibitor treated patients with shorter time to disease progression and less tumor regression. These findings suggest that monitoring patients for early PDGFR? up-regulation will facilitate the identification of those who may benefit from the treatment with BRAF-I in combination with clinically approved PDGFR? or Shh inhibitors.

SUBMITTER: Sabbatino F 

PROVIDER: S-EPMC4039118 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.

Sabbatino Francesco F   Wang Yangyang Y   Wang Xinhui X   Flaherty Keith T KT   Yu Ling L   Pepin David D   Scognamiglio Giosue G   Pepe Stefano S   Kirkwood John M JM   Cooper Zachary A ZA   Frederick Dennie T DT   Wargo Jennifer A JA   Ferrone Soldano S   Ferrone Cristina R CR  

Oncotarget 20140401 7


Control of BRAF(V600E) metastatic melanoma by BRAF inhibitor (BRAF-I) is limited by intrinsic and acquired resistance. Growth factor receptor up-regulation is among the mechanisms underlying BRAF-I resistance of melanoma cells. Here we demonstrate for the first time that PDGFRα up-regulation causes BRAF-I resistance. PDGFRα inhibition by PDGFRα-specific short hairpin (sh)RNA and by PDGFRα inhibitors restores and increases melanoma cells' sensitivity to BRAF-I in vitro and in vivo. This effect re  ...[more]

Similar Datasets

| S-EPMC10701685 | biostudies-literature
| S-EPMC9048514 | biostudies-literature
| S-EPMC3020967 | biostudies-literature
2019-12-31 | GSE130367 | GEO
| S-EPMC4965574 | biostudies-literature
2016-03-14 | E-GEOD-77042 | biostudies-arrayexpress
| S-ECPF-GEOD-21166 | biostudies-other
| S-EPMC4001781 | biostudies-literature
| S-EPMC3768265 | biostudies-literature
| S-EPMC3447223 | biostudies-literature